Association between duration of gonadotrophin‐releasing hormone agonist use and cardiovascular risks: A population‐based competing‐risk analysis

BACKGROUND: Although androgen deprivation therapy has known cardiovascular risks, it is unclear if its duration is related to cardiovascular risks. This study thus aimed to investigate the associations between gonadotrophin‐releasing hormone (GnRH) agonist use duration and cardiovascular risks. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Jeffrey S. K., Tang, Pias, Hui, Jeremy M. Ho, Lee, Yan H. A., Dee, Edward C., Ng, Kenrick, Liu, Kang, Tse, Gary, Ng, Chi Fai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804360/
https://www.ncbi.nlm.nih.gov/pubmed/35915869
http://dx.doi.org/10.1002/pros.24423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804360/
https://www.ncbi.nlm.nih.gov/pubmed/35915869
http://dx.doi.org/10.1002/pros.24423

Ejemplares similares